TY - JOUR
T1 - Transcriptome profile of human colorectal adenomas
AU - Sabates-Bellver, Jacob
AU - Van Der Flier, Laurens G.
AU - De Palo, Mariagrazia
AU - Cattaneo, Elisa
AU - Maake, Caroline
AU - Rehrauer, Hubert
AU - Laczko, Endre
AU - Kurowski, Michal A.
AU - Bujnicki, Janusz M.
AU - Menigatti, Mirco
AU - Luz, Judith
AU - Ranalli, Teresa V.
AU - Gomes, Vito
AU - Pastorelli, Alfredo
AU - Faggiani, Roberto
AU - Anti, Marcello
AU - Jiricny, Josef
AU - Clevers, Hans
AU - Marra, Giancarlo
PY - 2007/12/1
Y1 - 2007/12/1
N2 - Colorectal cancers are believed to arise predominantly from adenomas. Although these precancerous lesions have been subjected to extensive clinical, pathologic, and molecular analyses, little is currently known about the global gene expression changes accompanying their formation. To characterize the molecular processes underlying the transformation of normal colonic epithelium, we compared the transcriptomes of 32 prospectively collected adenomas with those of normal mucosa from the same individuals. Important differences emerged not only between the expression profiles of normal and adenomatous tissues but also between those of small and large adenomas. A key feature of the transformation process was the remodeling of the Wnt pathway reflected in patent overexpression and underexpression of 78 known components of this signaling cascade. The expression of 19 Wnt targets was closely correlated with clear up-regulation of KIAA1199, whose function is currently unknown. In normal mucosa, KIAA1199 expression was confined to cells in the lower portion of intestinal crypts, where Wnt signaling is physiologically active, but it was markedly increased in all adenomas, where it was expressed in most of the epithelial cells, and in colon cancer cell lines, it was markedly reduced by inactivation of the B-catenin/T-cell factor(s) transcription complex, the pivotal mediator of Wnt signaling. Our transcriptomic profiles of normal colonic mucosa and colorectal adenomas shed new light on the early stages of colorectal tumorigenesis and identified KIAA1199 as a novel target of the Wnt signaling pathway and a putative marker of colorectal adenomatous transformation.
AB - Colorectal cancers are believed to arise predominantly from adenomas. Although these precancerous lesions have been subjected to extensive clinical, pathologic, and molecular analyses, little is currently known about the global gene expression changes accompanying their formation. To characterize the molecular processes underlying the transformation of normal colonic epithelium, we compared the transcriptomes of 32 prospectively collected adenomas with those of normal mucosa from the same individuals. Important differences emerged not only between the expression profiles of normal and adenomatous tissues but also between those of small and large adenomas. A key feature of the transformation process was the remodeling of the Wnt pathway reflected in patent overexpression and underexpression of 78 known components of this signaling cascade. The expression of 19 Wnt targets was closely correlated with clear up-regulation of KIAA1199, whose function is currently unknown. In normal mucosa, KIAA1199 expression was confined to cells in the lower portion of intestinal crypts, where Wnt signaling is physiologically active, but it was markedly increased in all adenomas, where it was expressed in most of the epithelial cells, and in colon cancer cell lines, it was markedly reduced by inactivation of the B-catenin/T-cell factor(s) transcription complex, the pivotal mediator of Wnt signaling. Our transcriptomic profiles of normal colonic mucosa and colorectal adenomas shed new light on the early stages of colorectal tumorigenesis and identified KIAA1199 as a novel target of the Wnt signaling pathway and a putative marker of colorectal adenomatous transformation.
UR - http://www.scopus.com/inward/record.url?scp=37849013557&partnerID=8YFLogxK
U2 - 10.1158/1541-7786.MCR-07-0267
DO - 10.1158/1541-7786.MCR-07-0267
M3 - Article
C2 - 18171984
AN - SCOPUS:37849013557
SN - 1541-7786
VL - 5
SP - 1263
EP - 1275
JO - Molecular Cancer Research
JF - Molecular Cancer Research
IS - 12
ER -